Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 111

  • Showing results for pachner a. Search instead for Pahner A (1 item)
1.

Chemokine biomarkers in central nervous system tissue and cerebrospinal fluid in the Theiler's virus model mirror those in multiple sclerosis.

Pachner AR, Li L, Gilli F.

Cytokine. 2015 Jun 30. pii: S1043-4666(15)00245-8. doi: 10.1016/j.cyto.2015.06.010. [Epub ahead of print]

PMID:
26141421
2.

Late Occurrence of PML in a Patient Treated for Lymphoma with Immunomodulatory Chemotherapies, Bendamustine, Rituximab, and Ibritumomab Tiuxetan.

Lane MA, Renga V, Pachner AR, Cohen JA.

Case Rep Neurol Med. 2015;2015:892047. doi: 10.1155/2015/892047. Epub 2015 Jan 29.

3.

Teriflunomide and its mechanism of action in multiple sclerosis.

Bar-Or A, Pachner A, Menguy-Vacheron F, Kaplan J, Wiendl H.

Drugs. 2014 Apr;74(6):659-74. doi: 10.1007/s40265-014-0212-x. Review.

4.

Critical analysis of treatment trials of rhesus macaques infected with Borrelia burgdorferi reveals important flaws in experimental design.

Wormser GP, Baker PJ, O'Connell S, Pachner AR, Schwartz I, Shapiro ED.

Vector Borne Zoonotic Dis. 2012 Jul;12(7):535-8. doi: 10.1089/vbz.2012.1012. Epub 2012 May 23. Review.

5.

A second case of Marburg's variant of multiple sclerosis with vasculitis and extensive demyelination.

Elenein RG, Sharer LR, Cook SD, Pachner AR, Michaels J, Hillen ME.

Mult Scler. 2011 Dec;17(12):1531-8. doi: 10.1177/1352458511414042. Epub 2011 Aug 3.

PMID:
21816761
6.

The effect of FTY720 in the Theiler's virus model of multiple sclerosis.

Li L, Matsumoto M, Seabrook TJ, Cojean C, Brinkman V, Pachner AR.

J Neurol Sci. 2011 Sep 15;308(1-2):41-8. doi: 10.1016/j.jns.2011.06.029. Epub 2011 Jul 2.

PMID:
21726878
7.

Experimental models of multiple sclerosis.

Pachner AR.

Curr Opin Neurol. 2011 Jun;24(3):291-9. doi: 10.1097/WCO.0b013e328346c226. Review.

PMID:
21519255
8.

Plasma cells in the central nervous system in the Theiler's virus model of multiple sclerosis.

Pachner AR, Li L, Lagunoff D.

J Neuroimmunol. 2011 Mar;232(1-2):35-40. doi: 10.1016/j.jneuroim.2010.09.026. Epub 2010 Oct 20.

PMID:
20961623
9.

Do we need to broaden the spectrum of Lyme neuroborreliosis?

Pachner AR.

J Neurol Sci. 2010 Aug 15;295(1-2):8-9. doi: 10.1016/j.jns.2010.05.007. Epub 2010 Jun 8. No abstract available.

PMID:
20621799
10.

Recommendations for clinical use of data on neutralising antibodies to interferon-beta therapy in multiple sclerosis.

Polman CH, Bertolotto A, Deisenhammer F, Giovannoni G, Hartung HP, Hemmer B, Killestein J, McFarland HF, Oger J, Pachner AR, Petkau J, Reder AT, Reingold SC, Schellekens H, Sørensen PS.

Lancet Neurol. 2010 Jul;9(7):740-50. doi: 10.1016/S1474-4422(10)70103-4.

PMID:
20610349
11.

Effect of neutralizing antibodies on biomarker responses to interferon beta: the INSIGHT study.

Pachner AR, Warth JD, Pace A, Goelz S; INSIGHT investigators.

Neurology. 2009 Nov 3;73(18):1493-500. doi: 10.1212/WNL.0b013e3181bf98db. Erratum in: Neurology. 2010 Mar 16;74(11):936.

PMID:
19884577
12.

Effect of anti-IFN{beta} antibodies on MRI lesions of MS patients in the BECOME study.

Pachner AR, Cadavid D, Wolansky L, Skurnick J.

Neurology. 2009 Nov 3;73(18):1485-92. doi: 10.1212/WNL.0b013e3181bf9919.

PMID:
19884576
13.

Efficacy of treatment of MS with IFNbeta-1b or glatiramer acetate by monthly brain MRI in the BECOME study.

Cadavid D, Wolansky LJ, Skurnick J, Lincoln J, Cheriyan J, Szczepanowski K, Kamin SS, Pachner AR, Halper J, Cook SD.

Neurology. 2009 Jun 9;72(23):1976-83. doi: 10.1212/01.wnl.0000345970.73354.17. Epub 2009 Mar 11.

PMID:
19279320
14.

The multiple sclerosis severity score (MSSS) predicts disease severity over time.

Pachner AR, Steiner I.

J Neurol Sci. 2009 Mar 15;278(1-2):66-70. doi: 10.1016/j.jns.2008.11.020. Epub 2009 Jan 12.

PMID:
19138773
15.

Management of neutralizing antibodies against beta-IFN in beta-IFN-treated multiple sclerosis patients.

Pachner AR, Brady J, Steiner I, Narayan K.

J Neurol. 2008 Nov;255(11):1815-7. doi: 10.1007/s00415-008-0854-2. Epub 2008 Nov 22. No abstract available.

PMID:
19031099
16.

Measurement of binding anti-IFNbeta antibodies in IFNbeta-treated MS patients: lessons for the clinician and basic scientist.

Pachner AR.

J Neuroimmunol. 2008 Feb;194(1-2):5-6. Epub 2007 Nov 26. No abstract available.

PMID:
18031830
17.

Neutralizing anti-IFNbeta antibodies: clarity and confusion.

Pachner AR.

Mult Scler. 2007 Nov;13(9):1081-2. No abstract available.

PMID:
17967835
18.

The neurotropic herpes viruses: herpes simplex and varicella-zoster.

Steiner I, Kennedy PG, Pachner AR.

Lancet Neurol. 2007 Nov;6(11):1015-28. Review.

PMID:
17945155
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk